Stock Appreciation Rights

A stock appreciation right (SAR) is an equity award that entitles an employee to receive the gain on a share price increase above a base price, without requiring the employee to buy or hold the underlying stock. Unlike a call option, which the holder must exercise and pay for, a SAR is paid out automatically when vested, often in cash, and the employee never takes capital risk.

SARs versus options: why the difference matters

A call option grants you the right to buy a share at a fixed price. If you exercise, you must pay that price in cash. A stock appreciation right grants you the cash equivalent of the gain, without the cash outlay.

Imagine a company trading at $10 per share grants you 1,000 SARs with a grant price of $10. If the stock rises to $15, your 1,000 SARs are worth $5,000 (the $5 per share gain). When you exercise or the SARs vest, the company pays you $5,000 in cash (or $5,000 worth of shares). You never spent a dime.

With a $10 call option, you would need to spend $10,000 to buy 1,000 shares at $10 to capture the $5,000 gain. SARs eliminate this capital requirement. They also eliminate the holding-period requirement: SARs are cash-settled regardless of how long you hold them after vesting.

The cost to the company is also lower. An option is an economic grant of one full share’s worth of upside (from $10 to any higher price). A SAR grants only the appreciation (from $10 to the current price). If the stock is at $30, the option is worth $20 per share; the SAR is worth $20 per share. They converge at large upside. But at small upside, a SAR is cheaper: at $15, the option is still worth $5 (intrinsic value) plus time value; the SAR is worth exactly $5, with no time component.

How SARs are typically structured

SARs usually vest over four years with a one-year cliff, matching the vesting of restricted stock or RSUs. An employee granted 1,000 SARs will vest 250 per year (one-quarter annually) for four years.

SARs can be “settled” in two ways: cash or shares. Cash-settled SARs result in a cash payment equal to the appreciation; the company accrues a liability on the balance sheet and remeasures it each quarter. Share-settled SARs result in the issuance of shares equal to the appreciation value; the company issues shares from its treasury or the share count expands.

Most public companies use share-settled SARs to preserve cash and align with traditional equity structures. Private companies often use cash-settled SARs to avoid dilution and maintain a clean cap table.

Taxation of SARs

A SAR is taxable to the employee as ordinary income at the moment of vesting and settlement. The taxable amount is the spread: if the grant price was $10 and the vesting price was $15, the employee includes $5 per SAR in ordinary income. This is not capital gains treatment, so the tax rate is the employee’s marginal ordinary-income rate.

The company receives a tax deduction equal to the amount the employee must include in income. This is advantageous: a company that issues 1,000 SARs worth $5,000 total deducts $5,000 against its taxable income.

From an accounting perspective, the company must classify cash-settled SARs as a liability and remeasure the liability at fair value each quarter. If the stock rises from $15 to $20 during a quarter when SARs are unvested, the company must record an expense (remeasurement of the liability) even though the employee is not yet taxed. This can create volatility in earnings if many employees hold large SAR grants.

SARs in public companies

Public companies often issue SARs as a lean alternative to stock options or RSUs. SARs are particularly useful when the stock price is volatile: they cap the company’s accounting expense (since it is cash-settled) and provide employees with downside protection (if the stock falls below the grant price, the SAR is worthless but the employee did not lose their own cash).

Some public companies use performance-vesting SARs, where vesting is contingent on hitting earnings targets or share price hurdles. These are more complex to value and account for but align employee payouts tightly with company performance.

SARs in private companies

Private companies use SARs less frequently because the valuation is harder. A SAR’s value depends on the share price, which for a private company must be determined by a 409A appraisal (an independent, qualified appraiser valuation). If the SAR grant price is set at $10 per share via appraisal, and 18 months later the company is re-appraised at $12 per share, the SARs have appreciated $2 per share. But there is no market for the shares: the employee cannot sell them.

Some private companies use phantom stock instead of SARs because phantom stock is simpler to explain and document. Phantom stock grants the full share value at settlement; SARs grant only the appreciation. For retention purposes, phantom stock is often more generous and psychologically clearer.

The accounting complexity

Cash-settled SARs require the company to record an expense each quarter equal to the change in fair value of the liability. If the company has 10,000 vested SARs, the grant price was $10, and the current share price is $12, the company’s liability is $20,000. If next quarter the share price is $15, the liability rises to $50,000, and the company records a $30,000 non-cash expense.

This “mark-to-market” accounting can be disruptive to earnings. Companies that issue many SARs must be prepared to explain to investors why earnings are volatile despite stable business performance. Some companies hedge this by purchasing put options or entering into collars to limit the upside volatility of their SAR liabilities.

Share-settled SARs avoid this liability-remeasurement trap because they settle in shares (not cash), but they create share-count dilution and complicate the cap table.

SARs versus phantom stock

Phantom stock and SARs are the closest cousins. Both are cash-settled equity awards. The key difference: phantom stock grants the full share value at settlement, while a SAR grants only the appreciation. Phantom stock grants vested shares at a price of $15 equal $15 per share in cash. A SAR with the same grant price of $10 equals only $5 per share at $15 stock price.

For employees, phantom stock is more generous (you get the full $15, not just the $5 gain). For the company, SARs are leaner (lower cash cost, lower balance-sheet liability).

Phantom stock is also more common in private companies, while SARs are more common in public companies (where share-settled SARs avoid cash drain) and large institutions with mature equity programs.

SARs versus restricted stock

A grant of restricted stock in a public company is simpler to account for and understand. You receive X shares, subject to vesting and forfeiture. At vest, you have X shares and owe ordinary-income tax on their fair value at that date.

A SAR is a notional right: you never own the underlying shares. This avoids voting rights, dividend complications, and holding period requirements. But it also means the employee has no equity upside beyond the appreciation—no claim on the cash the company retained and reinvested.

For retention, restricted stock is often more powerful because the employee is a genuine shareholder once vested. SARs are a financial instrument: pure value transfer with no ownership.

When SARs are used tactically

Some mature private companies use SARs to incentivize short-term performance, since SARs can be cash-settled on a shorter cycle (e.g., quarterly or annual cash payouts if performance targets are hit). This creates a semi-bonus dynamic rather than pure equity.

Public companies sometimes issue “tandem” SARs alongside stock options: the employee can choose to exercise the option (and buy the shares) or cash in the SAR (and receive the gain). This flexibility is attractive to employees who want to choose between ownership and liquidity.

See also